THE USE OF MONOCLONAL ANTIBODIES (TIXAGEVIMAB AND CIGLAVIMAB) FOR PRE-EXPOSURE PROPHYLAXIS OF SEVERE COVID-19 INFECTION IN PATIENTS ON HEMODIALYSIS.

  Back

15 Apr 2024 5:45 p.m. 6:45 p.m.

WCN24-AB-2328, Poster Board= MON-236

Elena Zakharova Poster Presenter